Múdry, P., Kýr, M., Rohleder, O., Mahdal, M., Staniczková Zambo, I., Ježová, M., . . . Štěrba, J. (2021). Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis. J Bone Oncol.
Citação norma ChicagoMúdry, Peter, Michal Kýr, Ondřej Rohleder, Michal Mahdal, Iva Staniczková Zambo, Marta Ježová, Tomáš Tomáš, and Jaroslav Štěrba. "Improved Osteosarcoma Survival With Addition of Mifamurtide to Conventional Chemotherapy – Observational Prospective Single Institution Analysis." J Bone Oncol 2021.
MLA citiranjeMúdry, Peter, et al. "Improved Osteosarcoma Survival With Addition of Mifamurtide to Conventional Chemotherapy – Observational Prospective Single Institution Analysis." J Bone Oncol 2021.